HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,529-6,540 of 27,277
Drug study icon
TerminatedNCT02088060

Cannabidiol for Schizophrenia

Official study title

A Four-week, Multicentre, Double-blinded, Randomised, Active- and Placebo- Controlled, Parallel-group Trial Investigating Efficacy and Safety of Cannabidiol in Acute, Early-stage Schizophrenic Patients

This study ended early.

Multiple locations, including Glostrup Municipality
SchizophreniaMedication studyAges 18–65
Countries
Denmark, Germany
Sponsor
Central Institute of Mental Health, Mannheim
Drug study icon
SuspendedEUCTR 2012-004335-23

A four-week, multicentre, double-blinded, randomised, active- and placebo-controlled, parallel-group trial investigating efficacy and safety of cannabidiol in acute, early-stage schizophrenic patie...

Recruitment is currently suspended.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Denmark
SchizophreniaHistorical research record
Countries
Denmark, Germany
Sponsor
Central Institute of Mental Health
Other study type icon
CompletedACTRN12623001231639

A further examination of the short-term anxiolytic effects of an Echinacea extract (EP107) in adults experiencing increased anxiety

Official study title

A further examination of the short-term anxiolytic effects of an Echinacea extract (EP107) in adults experiencing increased anxiety: A randomised, double-blind, placebo-controlled trial

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 18–80
Countries
Australia
Sponsor
Clinical Research Australia
Behavioral study icon
Active Not RecruitingNCT06609902

A Future Thinking Intervention for Comorbid Addiction and Bipolarity

Official study title

Future Self: An Episodic Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder

This study is no longer accepting new participants.

In Boston
Bipolarity, AddictionBehavioural studyAges 18+
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Behavioral study icon
CompletedNCT05158946

A Future-oriented Group Training for Suicidal Patients

Official study title

Randomized Controlled Trial Investigating the Effectiveness of Future-oriented Group Training for Suicidal Patients

This study has finished and is no longer accepting participants.

In Ghent
SuicidalityBehavioural studyAges 18+
Countries
Belgium
Sponsor
University Ghent
Drug study icon
WithdrawnNCT00512616

A Glutamate Transporter GLT1, in the Treatment of Bipolarity

Official study title

An Investigation of the Efficacy of the Glutamate Transporter GLT 1 in the Treatment of Bipolar Depression

This study was withdrawn before enrollment.

In Bethesda
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Behavioral study icon
CompletedNCT03190707

A Good Start to Life - an Early Cross-sectorial Intervention

Official study title

Early Prevention of Social Inequality in Health - an Interdisciplinary and Cross-sectorial Intervention for Vulnerable Pregnant Women

This study has finished and is no longer accepting participants.

In Copenhagen
Personality disorders, Depression, ...Behavioural studyAges 18+
Countries
Denmark
Sponsor
Intersectoral Research Unit for Health Services

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.